Table 3 Short-term outcomes stratified by BMI status
Variables | Underweight | Normal weight | Overweight | p value |
|---|---|---|---|---|
Estimated blood loss (ml, mean ± SD) | 635.65±605.51 | 468.48±760.08 | 426.46±634.45 | 0.444 |
Blood transfusion | 178.26±285.97 | 198.13±493.80 | 152.56±368.28 | 0.777 |
Conversion | 3 (13.0) | 14 (14.6) | 12 (14.6) | 0.980 |
Operative time (min, mean ± SD) | 177.04±110.10 | 171.24±104.10 | 159.93±79.50 | 0.641 |
Postoperative length of stay (D) | 9.87±4.36 | 10.10±5.88 | 9.82±5.27 | 0.938 |
Complication | 11 (47.8) | 21 (21.9) | 14 (17.1) | 0.048* |
Bile leak | 5 (21.7) | 6 (6.3) | 4 (4.9) | 0.037* |
Introabodominal sepsis | 1 (4.3) | 4 (4.2) | 3 (3.7) | 0.432 |
Surgical site infection | 0 (0) | 3 (3.1) | 1 (1.2) | 0.737 |
Ascites | 3 (13.0) | 4 (4.2) | 0 (0) | 0.032* |
Pneumonia | 2 (8.7) | 3 (3.1) | 3 (3.7) | 0.758 |
Bleeding | 0 (0) | 1 (1.0) | 3 (3.7) | 0.647 |
Clavien classification | ||||
I-II | 5 (21.7) | 18 (18.8) | 15 (18.3) | 0.732 |
III–IV | 2 (8.7) | 3 (3.1) | 1 (1.2) | 0.042* |
Chemotherapy | 7 (30.4) | 38 (39.6) | 38/82 (46.3) | 0.442 |